Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
recommended marketing approval for their Omicron JN.1-adapted monovalent COVID-19 vaccine. The CHMP has recommended the approval of Comirnaty JN.1, the Omicron JN.1-adapted monovalent COVID-19 vaccine, for active immunization against the COVID-19 virus in individuals aged six months and above. The decision was based on the recommendation from the World Health Organization (WHO) Technical Advisory Group and the European Medicines Agency's Emergency Task Force (ETF). They recommended updating the COVID-19 vaccines to a monovalent (single strain) JN.1 composition for the 2024-2025 season. The latest CHMP opinion was based on previous clinical, non-clinical and real-world evidence underlining the safety and efficacy of the COVID-19 vaccines developed by PFE and BNTX. It also includes manufacturing and pre-clinical data demonstrating that JN.1-adapted monovalent vaccines provide a substantially improved response against multiple Omicron JN.1 sublineages, including KP.2, KP.3 and othe
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- CDC Narrows Age Recommendation for Use of RSV Vaccine [Yahoo! Finance]Yahoo! Finance
- Ceftriaxone Industry Research 2024: Effective Treatment of Multi-Drug Resistant Infections Bolsters Growth - Global Forecasts to 2032 [Yahoo! Finance]Yahoo! Finance
- Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline [CNBC]CNBC
- Is Pfizer Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Finland To Start Bird Flu Vaccinations For Humans [zero hedge]zero hedge
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/11/24 - Form 11-K
- PFE's page on the SEC website